Primo Biotechnology

About:

Primo aims at precision medicine and help the development of radioligand theranostics (RLT).

Website: https://primobt.com/en/

Top Investors: AVA Angels

Description:

Primo Biotechnology harnesses advanced molecular imaging and radiopharmaceutical science to provide precise clinical information via targeted radiopharmaceuticals. Primo Biotechnology aims to form a patient-centric healthcare model and establish doctor-patient relationships founded on trust towards conveying hope and happiness to all patients.

Total Funding Amount:

$6.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Taipei, T'ai-pei, Taiwan

Founded Date:

2023-01-01

Contact Email:

contact(AT)primobt.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2023-06-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai